Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT02047643
Collaborator
(none)
18
1
2
1.6
11

Study Details

Study Description

Brief Summary

Manually suspending an insulin pump at the beginning of aerobic exercise reduces the risk of exercise-associated hypoglycemia (low blood sugar) in patients with type 1 diabetes (T1D). However, since patients with T1D often do not make exercise-related adjustments to their insulin regimen, our group has developed an algorithm to initiate pump suspension in a user-independent manner upon projecting exercise-associated hypoglycemia. The current study seeks to test the efficacy of this algorithm by asking users to participate in a sports camp while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which will communicate electronically to a pump shutoff algorithm. On one of the days the algorithm will be used, while on the other day their normal insulin rate will continue for comparative purposes.

The investigators hypothesize that the use of an accelerometer-augmented computer algorithm for insulin pump suspension during exercise will result in significantly fewer episodes of hypoglycemia (both during exercise and in post-exercise monitoring) than in exercise without a pump suspension algorithm.

Condition or Disease Intervention/Treatment Phase
  • Device: Computer algorithm to initiate pump suspension
N/A

Detailed Description

Regular aerobic exercise confers a plethora of health benefits to all individuals and is considered an essential component of the management of type 1 diabetes (T1D) [1]. However, in contrast to non-diabetic subjects - in whom the increased muscle energy requirement during exercise leads to suppression of endogenous insulin secretion - patients with T1D are dependent upon exogenous insulin and are thus at risk for exercise-associated hypoglycemia [1]. Exercise-associated hypoglycemia is the most frequently reported adverse event related to exercise in diabetes [2] and hypoglycemia can occur during exercise or several hours afterwards [3,4]. Although previous research has shown that pre-meal dose reduction of subcutaneous insulin can be effective at decreasing the incidence of exercise-associated hypoglycemia [5], patients with T1D often do not perform such adjustments [6,7].

In contrast to subcutaneous insulin injections, which are reliant upon the patient or caretaker to determine dosage, the insulin pump provides a unique opportunity to avoid hypoglycemia via user-independent, computer-based algorithms for determining insulin delivery. Previous research conducted here at Stanford has demonstrated that algorithms based on continuous glucose monitor (CGM) data can prevent hypoglycemia in the sedentary setting by inducing insulin pump suspension [8-10]. In addition, a study of children and adolescents conducted at Stanford (as a center in the DirecNet group) demonstrated that suspending an insulin pump at the beginning of a period of moderate aerobic exercise reduces the risk of hypoglycemia during that exercise period and subsequently overnight [11]. Thus, by utilizing exercise-detecting accelerometers and an algorithm to initiate pump suspension during exercise, it is likely possible that people with diabetes could avoid exercise-associated hypoglycemia even if they failed to manually alter their pump settings. However, to date, no published studies have utilized accelerometer-derived data in an insulin pump suspension algorithm during exercise.

Accelerometers are light-weight motion-sensing devices that can be worn to provide information about the intensity and duration of physical activity [12]. They are small, inexpensive, and could easily be incorporated into current sensors and "patch" pumps. They can also be used independently or combined with a heart rate monitor (HRM) [13], although most commercially available HRMs currently require a chest strap that can be uncomfortable to wear. Previous studies evaluating the effect of physical activity on insulin sensitivity have utilized accelerometers (worn on a belt at the small of the back, the right side of the trunk in the mid-axillary line, or the left side of the chest) with and without HRMs for activity recognition during subjects' everyday lives. These data were used to classify activity as sedentary, light, moderate, or vigorous based on acceleration signal counts measured over one-minute intervals [13-17]. One study investigated four different accelerometers in a clinical research setting and found each to be very accurate in assessing the intensity of physical activity, regardless of subjects' body habitus [18]. Thus, these devices can provide a reliable means by which the onset, duration, and intensity of exercise can be recognized and reported in real-time to the other components of an artificial pancreas. When combined with CGM and insulin delivery data, this exercise information is a valuable tool in designing an algorithm to decrease or stop insulin delivery in order to decrease the risk of exercise-associated hypoglycemia.

In the first phase of this study (in press), 22 subjects with type 1 diabetes went about their everyday lives while wearing an insulin pump, CGM, and accelerometer/heart rate monitor. After the monitoring period, the devices were downloaded and the data were used to augment an existing predictive low glucose suspend (PLGS) algorithm to incorporate activity. In a computer simulator, the PLGS algorithm reduced hypoglycemia by 64%, compared to 73% and 76% reductions for the accelerometer-augmented and HRM-augmented algorithms, respectively.

In the next phase of this study, we seek to test the newly developed algorithm in a real-life setting in the form of a structured sports (soccer) camp to further see if modifications to the algorithm are required.

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
randomized crossover design. Subjects with type 1 diabetes participated in a structured soccer session on two separate dates at least one week apart. During one session a subject's basal insulin rate was continued ("off-algorithm"), while during the other session the algorithm (see "algorithm monitoring" below) was in effect ("on-algorithm"); the order of on- versus off-algorithm was chosen at random. The rate of hypoglycemia during exercise were compared between each group. Hypoglycemia was defined as (1) any meter blood glu cose (BG) reading of =60 mg/dl, (2) two consecutive meter BG readings =70 mg/dl done within one hour, or (3) any instance in which carbohydrates were given at a subject's request for symptoms of hypoglycemia (regardless of corre sponding meter BG reading).randomized crossover design. Subjects with type 1 diabetes participated in a structured soccer session on two separate dates at least one week apart. During one session a subject's basal insulin rate was continued ("off-algorithm"), while during the other session the algorithm (see "algorithm monitoring" below) was in effect ("on-algorithm"); the order of on- versus off-algorithm was chosen at random. The rate of hypoglycemia during exercise were compared between each group. Hypoglycemia was defined as (1) any meter blood glu cose (BG) reading of =60 mg/dl, (2) two consecutive meter BG readings =70 mg/dl done within one hour, or (3) any instance in which carbohydrates were given at a subject's request for symptoms of hypoglycemia (regardless of corre sponding meter BG reading).
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol
Actual Study Start Date :
Mar 12, 2014
Actual Primary Completion Date :
May 1, 2014
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: On-algorithm first, then Off-algorithm

Users will participate in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm is turned on; on the other day, the algorithm is turned off.

Device: Computer algorithm to initiate pump suspension
If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump
Other Names:
  • Augmented predictive low glucose suspend algorithm
  • Experimental: Off-algorithm first, then On-algorithm

    Users will participate in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm is turned on; on the other day, the algorithm is turned off.

    Device: Computer algorithm to initiate pump suspension
    If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump
    Other Names:
  • Augmented predictive low glucose suspend algorithm
  • Outcome Measures

    Primary Outcome Measures

    1. Count of Participants Experiencing a Hypoglycemic Event During Scheduled Exercise [Measurements occurring during exercise (up to 8 hours)]

      The primary outcome will be a hypoglycemic event defined as (1) any meter blood glucose (BG) reading of ≤60 mg/dl, (2) two consecutive meter BG readings ≤70 mg/dl done within one hour, or (3) any instance in which carbohydrates were given at a subject's request for symptoms of hypoglycemia

    Secondary Outcome Measures

    1. Count of Participants With Hypoglycemia in the Post Exercise Period [In the time following exercise until the following morning (up to 24 hours)]

      A hypoglycemic event was defined as (1) any meter blood glucose (BG) reading of ≤60 mg/dl, (2) two consecutive meter BG readings ≤70 mg/dl done within one hour, or (3) any instance in which carbohydrates were given at a subject's request for symptoms of hypoglycemia

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    8 Years to 25 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Clinical diagnosis of type 1 diabetes for 1-20 years. The diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not needed.

    • Age 8 to 25 years old.

    • On daily use of an insulin pump and not anticipating a change prior to the subject's completion of the study.

    • Willingness to allow for CGM insertion (if not already using a study-designated CGM) for use during the study.

    • HbA1c <10%.

    • Parent/guardian and subject understand the study protocol and agree to comply with it.

    • Informed Consent Form signed by the parent/guardian and Child Assent Form signed.

    Exclusion Criteria:
    • A history of recent injury to body or limb, Addison's disease, muscular disorder, organ/bone marrow transplant, heart disease, or use of any medication or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the exercise protocol.

    • Current use of glucocorticoid medication (by any route of administration).

    • Current use of a beta blocker medication.

    • Severe hypoglycemia resulting in seizure or loss of consciousness in the four weeks prior to sports camp (if a severe episode occurs after the first but prior to the scheduled second admission, the visit will be deferred).

    • Active infection (if at the time of the planned second visit an infection is present, the visit will be deferred).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford University Stanford California United States 94305

    Sponsors and Collaborators

    • Stanford University

    Investigators

    • Principal Investigator: Bruce A Buckingham, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Bruce Buckingham, Professor of Pediatric Endocrinology, Stanford University
    ClinicalTrials.gov Identifier:
    NCT02047643
    Other Study ID Numbers:
    • 29205
    First Posted:
    Jan 28, 2014
    Last Update Posted:
    Dec 27, 2019
    Last Verified:
    Dec 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Keywords provided by Bruce Buckingham, Professor of Pediatric Endocrinology, Stanford University
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title On-algorithm First, Then Off-algorithm Off-algorithm First, Then On-algorithm
    Arm/Group Description Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump. Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump.
    Period Title: Overall Study
    STARTED 9 9
    COMPLETED 9 9
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title All Participants
    Arm/Group Description Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump.
    Overall Participants 18
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    13.4
    (3.7)
    Sex: Female, Male (Count of Participants)
    Female
    8
    44.4%
    Male
    10
    55.6%
    Region of Enrollment (participants) [Number]
    United States
    18
    100%
    Hemoglobin A1c (percentage of glycosylated hemoglobin) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [percentage of glycosylated hemoglobin]
    8.0
    (1.1)
    Insulin pump type (Count of Participants)
    Medtronic
    11
    61.1%
    OmniPod
    4
    22.2%
    Animas
    2
    11.1%
    Tandem
    1
    5.6%

    Outcome Measures

    1. Primary Outcome
    Title Count of Participants Experiencing a Hypoglycemic Event During Scheduled Exercise
    Description The primary outcome will be a hypoglycemic event defined as (1) any meter blood glucose (BG) reading of ≤60 mg/dl, (2) two consecutive meter BG readings ≤70 mg/dl done within one hour, or (3) any instance in which carbohydrates were given at a subject's request for symptoms of hypoglycemia
    Time Frame Measurements occurring during exercise (up to 8 hours)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title On-algorithm Off-algorithm
    Arm/Group Description Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump. Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump.
    Measure Participants 18 18
    Count of Participants [Participants]
    3
    16.7%
    6
    NaN
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection On-algorithm, Off-algorithm
    Comments
    Type of Statistical Test Other
    Comments
    Statistical Test of Hypothesis p-Value .45
    Comments
    Method Fisher Exact
    Comments Two-sided Fisher Exact test
    2. Secondary Outcome
    Title Count of Participants With Hypoglycemia in the Post Exercise Period
    Description A hypoglycemic event was defined as (1) any meter blood glucose (BG) reading of ≤60 mg/dl, (2) two consecutive meter BG readings ≤70 mg/dl done within one hour, or (3) any instance in which carbohydrates were given at a subject's request for symptoms of hypoglycemia
    Time Frame In the time following exercise until the following morning (up to 24 hours)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title On-algorithm Off-algorithm
    Arm/Group Description Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump. Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump.
    Measure Participants 18 18
    Count of Participants [Participants]
    2
    11.1%
    4
    NaN
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection On-algorithm, Off-algorithm
    Comments
    Type of Statistical Test Other
    Comments
    Statistical Test of Hypothesis p-Value .66
    Comments
    Method Fisher Exact
    Comments Two-sided Fisher Exact test

    Adverse Events

    Time Frame Two 24-hour periods
    Adverse Event Reporting Description
    Arm/Group Title On-algorithm Off-algorithm
    Arm/Group Description Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump. Users participated in two sports camp sessions while wearing an insulin pump, continuous glucose monitor, and accelerometer/heart rate monitor (to detect exercise), which can communicate electronically to a pump shutoff algorithm that insulin delivery should be shut off. On one sports day, the algorithm was turned on; on the other day, the algorithm was turned off. If the computer algorithm senses impending risk for hypoglycemia it sends an alert to an on-site physician to recommend a manual suspension of the subject's insulin pump.
    All Cause Mortality
    On-algorithm Off-algorithm
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    On-algorithm Off-algorithm
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/18 (0%) 0/18 (0%)
    Other (Not Including Serious) Adverse Events
    On-algorithm Off-algorithm
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 3/18 (16.7%) 6/18 (33.3%)
    Metabolism and nutrition disorders
    Hypoglycemia 3/18 (16.7%) 6/18 (33.3%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Bruce Buckingham, M.D.
    Organization Stanford University
    Phone 408-356-0911
    Email buckingham@stanford.edu
    Responsible Party:
    Bruce Buckingham, Professor of Pediatric Endocrinology, Stanford University
    ClinicalTrials.gov Identifier:
    NCT02047643
    Other Study ID Numbers:
    • 29205
    First Posted:
    Jan 28, 2014
    Last Update Posted:
    Dec 27, 2019
    Last Verified:
    Dec 1, 2019